Determine the necessary mass, volume, or concentration for preparing a solution.
This is a demo store. No orders will be fulfilled.
Trastuzumab deruxtecan (anti-ERBB2) - Primary antibody, specific to ERBB2, >90% (SDS-PAGE&SEC), high purity, Human IgG1, BINDING AGENT of Receptor protein-tyrosine kinase erbB-2 binding agent, BINDING AGENT of Receptor protein-tyrosine kinase erbB-2 binding agent
- Host species: Human
- Reactive species: Human
- Isotype: Human IgG1
- Conjugation: MC-GGFG-DXd
In stock
Item Number
Ab183313
| SKU | Size | Availability |
Price | Qty |
|---|---|---|---|---|
|
Ab183313-100μg
|
100μg |
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
|
$159.90
|
|
|
Ab183313-1mg
|
1mg |
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
|
$759.90
|
|
|
Ab183313-5mg
|
5mg |
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
|
$1,699.90
|
|
|
Ab183313-10mg
|
10mg |
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
|
$2,999.90
|
|
Purity>90% (SDS-PAGE&SEC); Endotoxin Level<0.01EU/μg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Conjugated (MC-GGFG-DXd)